Breaking News

CSafe To Unveil First Frozen Active Temperature-Controlled Container

Aims to address the rapid growth of mRNA vaccines and in preparation for the commercialization of cell and gene therapies.

CSafe, a provider of a complete range of active and passive temperature-controlled shipping solutions for the pharmaceutical industry, will expand its active bulk air cargo container portfolio to integrate a new -20°C temperature setpoint for the CSafe RKN. The company will begin offering CSafe RKNs with the new frozen temperature setpoint on the control panel early next year. The CSafe RKN design requires minimal adjustment to accommodate the new -20°C temperature setpoint, limiting the need...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters